Prostate Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Featuring an interview with Dr Evan Yu, including the following topics: Efficacy, safety and optimal use of 177Lu-PSMA-617 (0:00) Current role of immuno-oncology (IO) in the management of metastatic prostate cancer (mCRPC) (18:13) Combining IO with other targeted agents for patients with mCRPC (24:50) CME information and select publications